Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Phase II Safety/Efficacy Study of A Combination Stem Cell Therapy That Develops Mature Stable Vessel Formation in Ischemic Limbs

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT00721006
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:42.687406+00:00
Published At
2014-05-09T00:00:00+00:00
Record Updated At
2014-05-09
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Critical Limb Ischemia", "Severe Leg Ischemia", "Peripheral Artery Disease", "Peripheral Vascular Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2014-05-09"
protocolSection.identificationModule.nctId
"NCT00721006"
protocolSection.identificationModule.officialTitle
"Phase II Safety/Efficacy Study of A Combination Stem Cell Therapy That Develops Mature Stable Vessel Formation in Ischemic Limbs"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Critical Limb Ischemia (protocolSection.conditionsModule.conditions)
  • Severe Leg Ischemia (protocolSection.conditionsModule.conditions)
  • Peripheral Artery Disease (protocolSection.conditionsModule.conditions)
  • Peripheral Vascular Disease (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.